IL-4 and IL-13 negatively regulate TNF-β- and IFN-γ-induced β-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 984-992

  Albanesi, Cristina ^a   Fairchild, Heather R ^b,c   Madonna, Stefania ^a   Scarponi, Claudia ^a   De Pità, Ornella ^a   Leung, Donald Y M ^b,c   Howell, Michael D ^b,c  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; GAMMA INTERFERON; HBD 2 PROTEIN; HBD 3 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; PROTEIN DERIVATIVE; STAT1 PROTEIN; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFECTION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; BIOSYNTHESIS; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BETA-DEFENSINS; BLOTTING, WESTERN; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-4; KERATINOCYTES; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548721076     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.984     Document Type: Article

References (41)

1. Ganz, T., and R. I. Lehrer. 1998. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10: 41-44.
2. Duits, L. A., B. Ravensbergen, M. Rademaker, P. S. Hiemstra, and P. H. Nibbering. 2002. Expression of β-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 106: 517-525.
3. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 2001. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276: 5707-5713.
4. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 1997. A peptide antibiotic from human skin. Nature 387: 861.
5. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347: 1151-1160.
6. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schroder, J. M. Wang, O. M. Howard, and J. J. Oppenheim. 1999. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
7. Oppenheim, J. J., A. Biragyn, L. W. Kwak, and D. Yang. 2003. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 62(Suppl. 2): ii17-ii21.
8. Selsted, M. E., and A. J. Ouellette. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6: 551-557.
9. Chen, C. I., S. Schaller-Bals, K. P. Paul, U. Wahn, and R. Bals. 2004. β-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J. Cyst. Fibros. 3: 45-50.
10. Nomura, I., E. Goleva, M. D. Howell, Q. A. Hamid, P. Y. Ong, C. F. Hall, M. A. Darst, B. Gao, M. Boguniewicz, J. B. Travers, and D. Y. Leung. 2003. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171: 3262-3269.
11. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85: 229-236.
12. Leung, D. Y., M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657.
13. Hartl, D., M. Griese, M. Kappler, G. Zissel, D. Reinhardt, C. Rebhan, D. J. Schendel, and S. Krauss-Etschmann. 2006. Pulmonary Th2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117: 204-211.
14. Laouini, D., S. Kawamoto, A. Yalcindag, P. Bryce, E. Mizoguchi, H. Oettgen, and R. S. Geha. 2003. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J. Allergy Clin. Immunol. 112: 981-987.
15. Howell, M. D., N. Novak, T. Bieber, S. Pastore, G. Girolomoni, M. Boguniewicz, J. Streib, C. Wong, R. L. Gallo, and D. Y. Leung. 2005. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J. Invest. Dermatol. 125: 738-745.
16. Howell, M. D., R. L. Gallo, M. Boguniewicz, J. F. Jones, C. Wong, J. E. Streib, and D. Y. Leung. 2006. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24: 341-348.
17. Federici, M., M. L. Giustizieri, C. Scarponi, G. Girolomoni, and C. Albanesi. 2002. Impaired IFN-γ-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J. Immunol. 169: 434-442.
18. Tobe, M., Y. Isobe, H. Tomizawa, T. Nagasaki, H. Takahashi, and H. Hayashi. 2003. A novel structural class of potent inhibitors of NF-κB activation: structure-activity relationships and biological effects of 6-aminoqunazoline derivatives. Bioorg. Med. Chem. 11: 3869-3878.
19. Hung, J. J., C. Y. Wu, P. C. Liao, and W. C. Chang. 2005. Hsp90α recruited by Sp1 is important for transcription of 12(S)-lipoxygenase in A431 cells. J. Biol. Chem. 280: 36283-36292.
20. Chen, C. Y., and D. V. Faller. 1999. Selective inhibition of protein kinase C isozymes by Fas ligation. J. Biol. Chem. 274: 15320-15328.
21. Tukey, J. 1977. Exploratory Data Analysis. Addison Wesley, Reading.
22. Ohmori, Y., R. D. Schreiber, and T. A. Hamilton. 1997. Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J. Biol. Chem. 272: 14899-14907.
23. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14: 301-331.
24. Greenhalgh, C. J., E. Rico-Bautista, M. Lorentzon, A. L. Thaus, P. O. Morgan, T. A. Willson, P. Zervoudakis, D. Metcalf, I. Street, N. A. Nicola, et al. 2005. SOCS2 negatively regulates growth hormone action in vitro and in vivo. J. Clin. Invest. 115: 397-406.
25. Chung, W. O., and B. A. Dale. 2004. Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect. Immun. 72: 352-358.
26. Hamid, Q., M. Boguniewicz, and D. Y. Leung. 1994. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94: 870-876.
27. Howell, M. D., A. Wollenberg, R. L. Gallo, M. Flaig, J. E. Streib, C. Wong, T. Pavicic, M. Boguniewicz, and D. Y. Leung. 2006. Cathelicidin deficiency predisposes to eczema herpeticum. J. Allergy Clin. Immunol. 117: 836-841.
28. Takeda, K., M. Kamanaka, T. Tanaka, T. Kishimoto, and S. Akira. 1996. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 157: 3220-3222.
29. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of STAT6 in IL-4 signalling. Nature 380: 627-630.
30. David, M., D. Ford, J. Bertoglio, A. L. Maizel, and J. Pierre. 2001. Induction of the IL-13 receptor α2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 20: 6660-6668.
31. Ohmori, Y., and T. A. Hamilton. 2000. Interleukin-4/STAT6 represses STAT1 and NF-κB-dependent transcription through distinct mechanisms. J. Biol. Chem. 275: 38095-38103.
32. Alexander, W. S., and D. J. Hilton. 2004. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22: 503-529.
33. Alexander, W. S., R. Starr, D. Metcalf, S. E. Nicholson, A. Farley, A. G. Elefanty, M. Brysha, B. T. Kile, R. Richardson, M. Baca, et al. 1999. Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction. J. Leukocyte Biol. 66: 588-592.
34. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921-924.
35. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, et al. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387: 924-929.
36. Nicholson, S. E., T. A. Willson, A. Farley, R. Starr, J. G. Zhang, M. Baca, W. S. Alexander, D. Metcalf, D. J. Hilton, and N. A. Nicola. 1999. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18: 375-385.
37. Hebenstreit, D., P. Luft, A. Schmiedlechner, G. Regl, A. M. Frischauf, F. Aberger, A. Duschl, and J. Horejs-Hoeck. 2003. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J. Immunol. 171: 5901-5907.
38. Travagli, J., M. Letourneur, J. Bertoglio, and J. Pierre. 2004. STAT6 and Ets-1 form a stable complex that modulates SOCS-1 expression by interleukin-4 in keratinocytes. J. Biol. Chem. 279: 35183-35192.
39. Rotz, L. D., D. A. Dotson, I. K. Damon, and J. A. Becher. 2001. Vaccinia (small-pox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm. Rep. 50: 1-25.
40. Howell, M. D., J. E. Streib, N. Novak, T. Bieber, M. Boguniewicz, S. Pastore, G. Girolomoni, and D. Y. Leung. 2006. Deficient HBD-3 in the skin of atopic dermatitis patients increases susceptibility to recurrent viral skin infections. J. Allergy Clin. Immunol. 117: S186 (Abstract 721).
41. Quinones-Mateu, M. E., M. M. Lederman, Z. Feng, B. Chakraborty, J. Weber, H. R. Rangel, M. L. Marotta, M. Mirza, B. Jiang, P. Kiser, et al. 2003. Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17: F39-F48.